
UNITEDHEALTH GROUP INC (UNH) received a 77% rating from Validea's Martin Zweig Growth Investor model, which targets companies with accelerating earnings and sales, reasonable valuations, and low debt. This score, while indicating some underlying fundamental strength, is below the 80% and 90% thresholds for general and strong interest, respectively. UNH demonstrated passes on key metrics such as P/E ratio, sales growth, and long-term EPS growth, but failed on revenue growth relative to EPS and the consistency of recent earnings growth rates.
UnitedHealth Group (UNH) scores a 77% on Validea's Martin Zweig-based Growth Investor model, indicating some fundamental appeal but falling short of the 80% and 90% thresholds that signal general or strong interest from this specific strategy. The analysis reveals a mixed profile for the large-cap health insurance firm. On the positive side, UNH passes on several key criteria, including its P/E ratio, sales growth rate, current quarter earnings performance, and long-term EPS growth. Furthermore, the model positively flags the company's earnings persistence and insider transaction activity. However, significant weaknesses were identified, preventing a higher score. Notably, UNH fails on the metric comparing revenue growth to EPS growth, suggesting that bottom-line expansion may not be fully supported by top-line acceleration. The model also flags a failure in the earnings growth rate over the past several quarters and notes that the current quarter's EPS growth, while positive, does not exceed the company's historical growth rate. This combination suggests that while current performance has strengths, the pattern of consistent, *accelerating* growth favored by the Zweig model is not present.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment